Berliner Boersenzeitung - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.305338
AFN 82.06272
ALL 98.237936
AMD 450.393493
ANG 2.098009
AOA 1075.016948
ARS 1470.680962
AUD 1.797024
AWG 2.110175
AZN 1.983107
BAM 1.953774
BBD 2.365547
BDT 142.93544
BGN 1.954895
BHD 0.441975
BIF 3447.79123
BMD 1.172319
BND 1.49786
BOB 8.095605
BRL 6.386209
BSD 1.171685
BTN 100.346945
BWP 15.64238
BYN 3.834157
BYR 22977.459406
BZD 2.35338
CAD 1.602971
CDF 3383.313846
CHF 0.933225
CLF 0.02883
CLP 1106.352775
CNY 8.410277
CNH 8.42339
COP 4749.804278
CRC 592.290873
CUC 1.172319
CUP 31.066463
CVE 110.903791
CZK 24.644504
DJF 208.344591
DKK 7.460916
DOP 70.456182
DZD 152.007489
EGP 58.242939
ERN 17.58479
ETB 159.933661
FJD 2.636253
FKP 0.859711
GBP 0.86312
GEL 3.177044
GGP 0.859711
GHS 12.182471
GIP 0.859711
GMD 83.80846
GNF 10147.596282
GTQ 9.004893
GYD 245.128359
HKD 9.202596
HNL 30.890898
HRK 7.534144
HTG 153.770547
HUF 400.114596
IDR 19071.291307
ILS 3.926297
IMP 0.859711
INR 100.476971
IQD 1535.738358
IRR 49383.952848
ISK 142.976378
JEP 0.859711
JMD 187.000874
JOD 0.831119
JPY 172.073319
KES 151.812611
KGS 102.519814
KHR 4713.896336
KMF 492.958703
KPW 1055.085172
KRW 1609.863899
KWD 0.358155
KYD 0.976429
KZT 608.778724
LAK 25263.481573
LBP 105039.814409
LKR 352.213783
LRD 235.049299
LSL 20.856085
LTL 3.461554
LVL 0.709124
LYD 6.338456
MAD 10.556737
MDL 19.830198
MGA 5193.374785
MKD 61.52552
MMK 2460.949065
MNT 4207.234357
MOP 9.473761
MRU 46.546912
MUR 52.883124
MVR 18.059126
MWK 2035.735816
MXN 21.830638
MYR 4.971796
MZN 74.981553
NAD 20.855816
NGN 1798.419923
NIO 43.082789
NOK 11.836006
NPR 160.556879
NZD 1.95685
OMR 0.450755
PAB 1.171595
PEN 4.155281
PGK 4.835818
PHP 66.343887
PKR 333.231604
PLN 4.243784
PYG 9337.556324
QAR 4.267948
RON 5.07274
RSD 117.113572
RUB 92.024727
RWF 1681.105959
SAR 4.396635
SBD 9.773538
SCR 16.526453
SDG 703.96548
SEK 11.167385
SGD 1.500469
SHP 0.921259
SLE 26.37312
SLL 24582.955062
SOS 669.993468
SRD 43.755059
STD 24264.643796
SVC 10.251632
SYP 15242.341676
SZL 20.855855
THB 38.193915
TJS 11.253606
TMT 4.114841
TND 3.418564
TOP 2.745692
TRY 46.955992
TTD 7.948825
TWD 34.142046
TZS 3095.148215
UAH 48.938405
UGX 4211.632726
USD 1.172319
UYU 47.042423
UZS 14917.763773
VES 131.637158
VND 30638.566407
VUV 139.299685
WST 3.212728
XAF 655.288674
XAG 0.032061
XAU 0.000355
XCD 3.168252
XDR 0.814327
XOF 652.98208
XPF 119.331742
YER 283.525203
ZAR 20.857062
ZMK 10552.277921
ZMW 28.38157
ZWL 377.486355
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

(H.Schneide--BBZ)